Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

USA - NYSE:MPW - US58463J3041 - REIT

5.04 USD
-0.06 (-1.18%)
Last: 11/19/2025, 2:58:21 PM
5.07 USD
+0.03 (+0.6%)
Pre-Market: 11/20/2025, 4:30:48 AM
Fundamental Rating

4

MPW gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 128 industry peers in the Diversified REITs industry. MPW scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MPW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MPW had negative earnings in the past year.
In the past year MPW had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
Each year in the past 5 years MPW had a positive operating cash flow.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

MPW has a worse Return On Assets (-9.45%) than 89.84% of its industry peers.
The Return On Equity of MPW (-29.62%) is worse than 89.06% of its industry peers.
MPW has a Return On Invested Capital of 1.93%. This is in the lower half of the industry: MPW underperforms 66.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MPW is in line with the industry average of 3.04%.
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROIC 1.93%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

MPW has a better Operating Margin (38.49%) than 84.38% of its industry peers.
MPW's Operating Margin has declined in the last couple of years.
MPW has a better Gross Margin (96.46%) than 97.66% of its industry peers.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
Industry RankSector Rank
OM 38.49%
PM (TTM) N/A
GM 96.46%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
The number of shares outstanding for MPW has been increased compared to 1 year ago.
The number of shares outstanding for MPW has been increased compared to 5 years ago.
The debt/assets ratio for MPW is higher compared to a year ago.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

MPW has an Altman-Z score of 0.00. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
MPW has a worse Altman-Z score (0.00) than 74.22% of its industry peers.
The Debt to FCF ratio of MPW is 931.91, which is on the high side as it means it would take MPW, 931.91 years of fcf income to pay off all of its debts.
MPW has a Debt to FCF ratio (931.91) which is in line with its industry peers.
MPW has a Debt/Equity ratio of 2.00. This is a high value indicating a heavy dependency on external financing.
MPW has a Debt to Equity ratio of 2.00. This is in the lower half of the industry: MPW underperforms 69.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Altman-Z 0
ROIC/WACC0.32
WACC6.08%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 2.07 indicates that MPW has no problem at all paying its short term obligations.
MPW has a Current ratio of 2.07. This is amongst the best in the industry. MPW outperforms 82.03% of its industry peers.
MPW has a Quick Ratio of 2.07. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.07, MPW belongs to the best of the industry, outperforming 82.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

MPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.50%, which is quite impressive.
MPW shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.19%.
The Revenue has been growing slightly by 3.11% on average over the past years.
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%

3.2 Future

Based on estimates for the next years, MPW will show a very strong growth in Earnings Per Share. The EPS will grow by 27.84% on average per year.
MPW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y90.15%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 32.40, which means the current valuation is very expensive for MPW.
MPW's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MPW is cheaper than 73.44% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MPW to the average of the S&P500 Index (35.42), we can say MPW is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 32.4
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MPW indicates a slightly more expensive valuation: MPW is more expensive than 60.16% of the companies listed in the same industry.
MPW's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 292.6
EV/EBITDA 15.99
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

MPW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MPW's earnings are expected to grow with 27.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.49%
EPS Next 3Y27.84%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.43%, MPW is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.49, MPW pays a bit more dividend than its industry peers.
MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 6.43%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of MPW are negative and hence is the payout ratio. MPW will probably not be able to sustain this dividend level.
DP-16.42%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (11/19/2025, 2:58:21 PM)

Premarket: 5.07 +0.03 (+0.6%)

5.04

-0.06 (-1.18%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners59.4%
Inst Owner Change-3.05%
Ins Owners17.29%
Ins Owner Change-0.07%
Market Cap3.03B
Revenue(TTM)995.55M
Net Income(TTM)-1.43B
Analysts51.76
Price Target4.95 (-1.79%)
Short Float %31.08%
Short Ratio17.62
Dividend
Industry RankSector Rank
Dividend Yield 6.43%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-11 2025-09-11 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5843.9%
Min EPS beat(2)-11757.5%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3817.81%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-1947.02%
EPS beat(12)3
Avg EPS beat(12)-1329.14%
EPS beat(16)7
Avg EPS beat(16)-980.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.51%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)5
Avg Revenue beat(12)-1.65%
Revenue beat(16)6
Avg Revenue beat(16)-1.31%
PT rev (1m)0%
PT rev (3m)-2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-65.39%
EPS NY rev (1m)-56.06%
EPS NY rev (3m)-485.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.4
P/S 3.29
P/FCF 292.6
P/OCF 16.11
P/B 0.63
P/tB 0.63
EV/EBITDA 15.99
EPS(TTM)-1
EYN/A
EPS(NY)0.16
Fwd EY3.09%
FCF(TTM)0.02
FCFY0.34%
OCF(TTM)0.31
OCFY6.21%
SpS1.53
BVpS8.04
TBVpS8.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROCE 2.45%
ROIC 1.93%
ROICexc 2%
ROICexgc 2.08%
OM 38.49%
PM (TTM) N/A
GM 96.46%
FCFM 1.12%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexgc growth 3Y-18.25%
ROICexgc growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Debt/EBITDA 12.68
Cap/Depr 43.72%
Cap/Sales 19.27%
Interest Coverage 0.92
Cash Conversion 24.7%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 0
F-Score4
WACC6.08%
ROIC/WACC0.32
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
EPS Next Y90.15%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%
EBIT growth 1Y54.29%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year124.92%
EBIT Next 3Y37.51%
EBIT Next 5Y20.65%
FCF growth 1Y116.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.04%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%

MEDICAL PROPERTIES TRUST INC / MPW FAQ

What is the fundamental rating for MPW stock?

ChartMill assigns a fundamental rating of 4 / 10 to MPW.


What is the valuation status for MPW stock?

ChartMill assigns a valuation rating of 3 / 10 to MEDICAL PROPERTIES TRUST INC (MPW). This can be considered as Overvalued.


Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?

MEDICAL PROPERTIES TRUST INC (MPW) has a profitability rating of 3 / 10.


What is the financial health of MEDICAL PROPERTIES TRUST INC (MPW) stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPW) is 4 / 10.


Can you provide the expected EPS growth for MPW stock?

The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPW) is expected to grow by 90.15% in the next year.